Stay updated on Nivolumab and Axitinib in RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Axitinib in RCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T23:49:24.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    An administrative update adds a new revision tag (v3.4.2) and removes older notices (lapse in government funding notice and v3.4.1), with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:27:12.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH Clinical Center status at the top of the page. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:38:14.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary option added; capitalization tweaks to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; and the revision version updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:00:21.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3 in the study documents section, with no changes to core study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:43:38.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations section consolidated under a single Locations heading, listing Maryland, New York, and Pennsylvania. Previous separate subsections for Maryland Locations, New York Locations, and Pennsylvania Locations were removed.
    Difference
    0.4%
    Check dated 2025-12-23T20:56:41.000Z thumbnail image

Stay in the know with updates to Nivolumab and Axitinib in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.